FDA Commissioner open to revising HRT warning labels due to benefits beyond menopausal symptoms, despite past breast cancer ...

The Food and Drug Administration is reassessing some warnings given about hormone therapy treatments for menopause that have ...

Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...

“The role of testosterone is just a lesson in gender bias,” says Kelly Casperson, MD, a urologist. “Because 100 percent of ...

A meeting held by the FDA Thursday spotlighted debate over black box warnings that have limited use of hormone treatment for ...

Overall, this suggests that the cumulative risk of breast cancer before age 55 for women taking estrogen/progestin is about 4 ...

Estrogen-progestin hormone therapy used to manage menopausal symptoms and other women’s health conditions is associated with ...

Puerto Rico’s governor has signed a bill that prohibits hormone therapy or gender-affirming surgeries for transgender youth, a move that has drawn sharp criticism from activists in the largely ...

Hormone therapy, formerly known as hormone replacement therapy (HRT), can make a big difference in counteracting these symptoms by supplementing the low hormone levels.

An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...